[DISCREPA study: treatment of advanced Parkinson's disease and use of second-line treatments in Catalonia]. Avila A, Pastor P, Planellas L, Gil-Villar MP, et al. Rev Neurol 2021;72:1-8.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Avila A, Pastor P, Planellas L, Gil-Villar MP, et al. [DISCREPA study: treatment of advanced Parkinson's disease and use of second-line treatments in Catalonia]. Rev Neurol 2021;72:1-8.
PMID: 33378073